Diagnosis of Common Dermopathies in Dialysis Patients: A Review and Update

Seminars in Dialysis

Volumn 25, Issue 4, 2012, Pages 408-418

  Markova, Alina ^a   Lester, Jenna ^a   Wang, Joanne ^a   Robinson Bostom, Leslie ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCINOSIS; CHRONIC KIDNEY FAILURE; HUMAN; NAIL DISEASE; RENAL REPLACEMENT THERAPY; SKIN DISEASE;

CALCINOSIS; HUMANS; KIDNEY FAILURE, CHRONIC; NAIL DISEASES; RENAL DIALYSIS; SKIN DISEASES;

EID: 84864024131     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2012.01109.x     Document Type: Article

References (75)

1. Udayakumar P, Balasubramanian S, Ramalingam KS, Lakshmi C, Srinivas CR, Mathew AC: Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol 72(2):119-125, 2006
2. Alston H, Burns A: Half and half nails. Nephrol Dial Transplant 4:361, 2011
3. Berghoff AT, English JC III: Imatinib mesylate-induced pseudoporphyria. J Am Acad Dermatol 63(1):e14-e16, 2010
4. Kurban MS, Boueiz A, Kibbi AG: Cutaneous manifestations of chronic kidney disease. Clin Dermatol 26(3):255-264, 2008
5. Salem A, Al Mokadem S, Attwa E, Abd El Raoof S, Ebrahim HM, Faheem KT: Nail changes in chronic renal failure patients under haemodialysis. J Eur Acad Dermatol Venereol 22(11):1326-1331, 2008
6. Kuo CC, Hung J, Tsai C, Chen Y: Uremic frost. CMAJ 182(17):E800, 2010
7. Pol-Rodriguez MM, Wanner M, Bhat P, Grossman ME: Uremic frost in a critically ill patient. Kidney Int 73(6):790, 2008
8. Walsh SR, Parada NA: Images in clinical medicine. Uremic frost. N Engl J Med 352(13):e13, 2005
9. Khanna D, Singal A, Kalra OP: Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis. Postgrad Med J 86(1021):641-647, 2010
10. Robinson-Bostom L, DiGiovanna JJ: Cutaneous manifestations of end-stage renal disease. J Am Acad Dermatol 43(6): 975-986, 2000; quiz 987-990.
11. Amatya B, Agrawal S, Dhali T, Sharma Sanjib, Pandey SS: Pattern of skin and nail changes in chronic renal failure in Nepal: a hospital-based study. J Dermatol 35(3):140-145, 2008
12. Szepietowski JC, Balaskas E, Taube K, Taberly A, Dupuy P: Quality of life in patients with uraemic xerosis and pruritus. Acta Derm Venereol 91(3):313-317, 2011
13. Avermaete A, Altmeyer P, Bacharach-Buhles M: Skin changes in dialysis patients: a review. Nephrol Dial Transplant 16(12):2293-2296, 2001
14. Falodun O, Ogunbiyi A, Salako B, George AK: Skin changes in patients with chronic renal failure. Saudi J Kidney Dis Transpl 22(2):268-272, 2011
15. Wang H, Yosipovitch G: New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 49(1):1-11, 2010
16. Castello M, Milani M: Efficacy of topical hydating and emollient lotion containin 10% urea ISDIN (R) plus dexpanthenol (Ureadin Rx 10) in the treatmen of skin xerosis and pruritus in hemodialyzed patiens: an open prospective pilot trial. Giornale Italiano di dermatologia e venerologia: organo ufficiale, Societa italiana di dermatologia e sifilogafia. 146(5):321-325, 2011
17. Sanai M, Aman S, Nadeem M, Kazmi AH: Dermatologic manifestations in patients of renal disease on haemodialysis. Journal of Pakistan Association of Dermatologists 20:163-168, 2010
18. Shibata M, Nagai K, Usami K, Tawada H, Taniguchi S: The quantitative evaluation of online haemodiafiltration effect on skin hyperpigmentation. Nephrol Dial Transplant 26(3):988-992, 2011
19. Moon SJ, Kim DK, Chang JH, Kim CH, Kim HW, Park SY, Han SH, Lee JE, Yoo TH, Han DS, Kang SW: The impact of dialysis modality on skin hyperpigmentation in haemodialysis patients. Nephrol Dial Transplant 24(9):2803-2809, 2009
20. Kocyigit I, Unal A, Tanriverdi F, Hayri Sipahioglu M, Tokgoz B, Oymak O, Utas C: Misdiagnosis of Addison's disease in a patient with end-stage renal disease. Ren Fail 33(1):88-91, 2011
21. Kazmierowski JA, Chusid MJ, Parrillo JE, Fauci AS, Wolff SM: Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol 114(4):531-535, 1978
22. Kho HS, Lee SW, Chung SC, Kim YK: Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88(3):316-319, 1999
23. Kaw D, Malhotra D: Platelet dysfunction and end-stage renal disease. Semin Dial 19(4):317-322, 2006
24. Talalla A, Halbrook H, Barbour BH, Kurze T: Subdural hematoma associated with long-term hemodialysis for chronic renal disease. JAMA 212(11):1847-1849, 1970
25. Sabovic M, Salobir B, Preloznik Zupan I, Bratina P, Bojec V, Buturovic Ponikvar J: The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis. Pathophysiol Haemost Thromb 34(6):274-278, 2005
26. Heistinger M, Stockenhuber F, Schneider B, Pabinger I, Brenner B, Wagner B, Balcke P, Lechner K, Kyrle PA: Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF. Kidney Int 38(6):1181-1186, 1990
27. Sriprakash K, Yong-Gee S: Multiple minute digitate hyperkeratoses associated with paraproteinaemia. Australas J Dermatol 49(4):233-236, 2008
28. Yang JH, Kim JK, Won CH, Chang SE, Lee MW, Choi JH, Moon KC: Isolated epidermolytic acanthoma in a renal transplant recipient. Ann Dermatol 23(3):415-416, 2011
29. Cordova KB, Oberg TJ, Malik M, Robinson-Bostom L: Dermatologic conditions seen in end-stage renal disease. Semin Dial 22(1):45-55, 2009
30. Saray Y, Seckin D, Bilezikci B: Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol 20(6):679-688, 2006
31. Karpouzis A, Giatromanolaki A, Sivridis E, Kouskoukis C: Acquired reactive perforating collagenosis: current status. J Dermatol 37(7):585-592, 2010
32. Hari Kumar KV, Prajapati J, Pavan G, Parthasarathy A, Jha R, Modi KD: Acquired perforating dermatoses in patients with diabetic kidney disease on hemodialysis. Hemodial Int 14(1):73-77, 2010
33. Lynde CB, Pratt MD: Clinical Images: acquired perforating dermatosis: association with diabetes and renal failure. CMAJ 181(9):615, 2009
34. Sezer E, Erkek E: Acquired perforating dermatosis successfully treated with photodynamic therapy. Photodermatol Photoimmunol Photomed 28(1):50-52, 2012
35. Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E: Calcinosis cutis: part I. Diagnostic pathway. J Am Acad Dermatol 65(1): 1-12; 2011, quiz 13-14.
36. Tan O, Atik B, Kizilkaya A, Ozer E, Kavukcu S: Extensive skin calcifications in an infant with chronic renal failure: metastatic calcinosis cutis. Pediatr Dermatol 23(3):235-238, 2006
37. Rivet J, Lebbé C, Urena P, Cordoliani F, Martinez F, Baglin AC, Aubert P, Aractingi S, Ronco P, Fournier P, Janin A: Cutaneous calcification in patients with end-stage renal disease: a regulated process associated with in situ osteopontin expression. Arch Dermatol 142(7):900-906, 2006
38. Walsh JS, Fairley JA: Calcifying disorders of the skin. J Am Acad Dermatol 33(5 Pt 1): 693-706, 1995; quiz 707-710.
39. Chung SD, Lu CW, Wu VC, Chen YS, Chang KC, Chu SH: Metastatic calcinosis cutis. QJM 102(5):359, 2009
40. Beus KS, Stack BC Jr: Calciphylaxis. Otolaryngol Clin North Am 37(4): 941-948, xii, 2004.
41. Brewster UC: Dermatological disease in patients with CKD. Am J Kidney Dis 51(2):331-344, 2008
42. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR: Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56(4):569-579, 2007
43. Brandenburg VM, Cozzolino M, Ketteler M: Calciphylaxis: a still unmet challenge. J Nephrol 24(2):142-148, 2011
44. Santo Domingo D, Stevenson ML, Auerbach J, Lerman J: Finasteride-induced pseudoporphyria. Arch Dermatol, 147(6):747-748, 2011
45. Vedvyas C, Winterfield LS, Vleugels RA: Calciphylaxis: a systematic review of existing and emerging therapies. J Am Acad Dermatol 2011. Aug 5. [Epub ahead of print].
46. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE: Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356(9234):1000-1001, 2000
47. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE: Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23(5):383-393, 2001
48. Ting WW, Stone MS, Madison KC, Kurtz K: Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139(7):903-906, 2003
49. Girardi M, Kay J, Elston DM, Leboit PE, Abu-Alfa A, Cowper SE: Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol 65(6):1095-1106, 2011
50. Haemel AK, Sadowski EA, Shafer MM, Djamali A: Update on nephrogenic systemic fibrosis: are we making progress? Int J Dermatol 50(6):659-666, 2011
51. Kendrick-Jones JC, Voss DM, De Zoysa JR: Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006. Nephrology (Carlton) 16(2):243-248, 2011
52. Deo A, Fogel M, Cowper SE: Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2(2):264-267, 2007
53. Othersen JB, Maize JC, Woolson RF, Budisavljevic MN: Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure. Nephrol Dial Transplant 22(11):3179-3185, 2007
54. Shabana WM, Cohan RH, Ellis JH, Hussain HK, Francis IR, Su LD, Mukherji SK, Swartz RD: Nephrogenic systemic fibrosis: a report of 29 cases. AJR Am J Roentgenol 190(3):736-741, 2008
55. Jalandhara N, Arora R, Batuman V: Nephrogenic systemic fibrosis and gadolinium-containing radiological contrast agents: an update. Clin Pharmacol Ther 89(6):920-923, 2011
56. Nazarian RM, Mandal RV, Kagan A, Kay J, Duncan LM: Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid. J Am Acad Dermatol 64(4):741-747, 2011
57. Gupta A, Shamseddin MK, Khaira A: Pathomechanisms of nephrogenic systemic fibrosis: new insights. Clin Exp Dermatol 36(7):763-768, 2011
58. Munoz-Santos C, Guilabert A, Moreno N, To-Figueras J, Badenas C, Darwich E, Herrero C: Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. Medicine (Baltimore) 89(2):69-74, 2010
59. Frank J, Poblete-Gutierrez P: Porphyria cutanea tarda - when skin meets liver. Best Pract Res Clin Gastroenterol 24(5):735-745, 2010
60. Sarkany RP: The management of porphyria cutanea tarda. Clin Exp Dermatol 26(3):225-232, 2001
61. Thunell S, Harper P: Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda--suggestions for a handling programme. Scand J Clin Lab Invest 60(7):561-579, 2000
62. Tchernitchko D, Robréau AM, Lefebvre T, Lamoril J, Deybach JC, Puy H: Comprehensive cytochrome P450 CYP1A2 gene analysis in French caucasian patients with familial and sporadic porphyria cutanea tarda. Br J Dermatol 166(2):425-429, 2012
63. Shieh S, Cohen JL, Lim HW: Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review. J Am Acad Dermatol 42(4):645-652, 2000
64. Phillips JD, Bergonia HA, Reilly CA, Franklin MR, Kushner JP: A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proc Natl Acad Sci USA 104(12):5079-5084, 2007
65. Ryali ME, Whittier WL: Bullous skin lesions in a patient undergoing chronic hemodialysis. Semin Dial 23(1):83-87, 2010
66. Sassa S: Modern diagnosis and management of the porphyrias. Br J Haematol 135(3):281-292, 2006
67. Munoz-Santos C, Guilabert A, Moreno N, Gimenez M, Darwich E, To-Figueras J, Herrero C: The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort. Br J Dermatol 165(3):486-491, 2011
68. Massone C, Ambros-Rudolph CM, Di Stefani A, Müllegger RR: Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis. Acta Derm Venereol 86(6):538-540, 2006
69. Cooke NS, McKenna K: A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine. Clin Exp Dermatol 32(1):64-66, 2007
70. Guiotoku MM, Pereira Fde P, Miot HA, Marques ME: Pseudoporphyria induced by dialysis treated with oral N-acetylcysteine. An Bras Dermatol 86(2):383-385, 2011
71. Kwong WT, Hsu S: Pseudoporphyria associated with voriconazole. J Drugs Dermatol 6(10):1042-1044, 2007
72. Riahi RR, Cohen PR: Voriconazole-associated phototoxicity. Dermatol Online J 17(2):15, 2011
73. Sharp MT, Horn TD: Pseudoporphyria induced by voriconazole. J Am Acad Dermatol 53(2):341-345, 2005
74. Tolland JP, McKeown PP, Corbett JR: Voriconazole-induced pseudoporphyria. Photodermatol Photoimmunol Photomed 23(1):29-31, 2007
75. Felix RH, Silva MF Jr, Almeida JB, Neto PB: Pseudoporphyria associated with hemodialysis. Kidney Int 79(1):140, 2011